Mitigation of Obesity-Promoted Diseases by Nigella sativa and Thymoquinone

Plant Foods for Human Nutrition

Volumn 67, Issue 2, 2012, Pages 111-119

  Vanamala, Jairam ^a,b   Kester, Andrew C ^a   Heuberger, Adam L ^a   Reddivari, Lavanya ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Bioactive compounds; Cancer; Nigella sativa; Nutraceuticals; Obesity; Thymoquinone; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; BENZOQUINONE DERIVATIVE; PLANT EXTRACT; THYMOQUINONE;

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; BLACK CUMIN; CARDIOVASCULAR DISEASE; CHEMISTRY; HUMAN; INSULIN RESISTANCE; METHODOLOGY; NEOPLASM; OBESITY; WEIGHT REDUCTION;

ANTIOXIDANTS; BENZOQUINONES; CARDIOVASCULAR DISEASES; CHEMORADIOTHERAPY, ADJUVANT; HUMANS; INSULIN RESISTANCE; NEOPLASMS; NIGELLA SATIVA; OBESITY; PLANT EXTRACTS; WEIGHT LOSS;

NIGELLA SATIVA;

EID: 84861678038     PISSN: 09219668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11130-012-0279-z     Document Type: Article

References (70)

1. Paredes-Lopez O, Cervantes-Ceja ML, Vigna-Perez M, Hernandez-Perez T (2010) Berries: Improving human health and healthy aging, and promoting quality life-a review. Plant Foods Hum Nutr 65: 299-308.
2. Millen AE, Subar AF, Graubard BI, Peters U, Hayes RB, Weissfeld JL, Yokochi LA, Ziegler RG (2007) Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr 86: 1754-1764.
3. Szajdek A, Borowska EJ (2008) Bioactive compounds and health-promoting properties of berry fruits: A review. Plant Foods Hum Nutr 63: 147-156.
4. Ramadan MF (2007) Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): An overview. Int J Food Sci Tech 42: 1208-1218.
5. Ali BH, Blunden G (2003) Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17: 299-305.
6. Dehkordi FR, Kamkhah AF (2008) Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 22: 447-452.
7. Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS (2004) The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol 94: 251-259.
8. Randhawa MA, Alghamdi MS (2011) Anticancer activity of Nigella sativa (black seed)-A review. Am J Chin Med 39: 1075-1091.
9. Norwood AA, Tan M, May M, Tucci M, Benghuzzi H (2006) Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells. Biomed Sci Instrum 42: 350-356.
10. Rchid H, Chevassus H, Nmila R, Guiral C, Petit P, Chokairi M, Sauvaire Y (2004) Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fund Clin Pharmacol 18: 525-529.
11. Vaughn N, Rizzo A, Doane D, Beverly JL, Gonzalez de Mejia E (2008) Intracerebroventricular administration of soy protein hydrolysates reduces body weight without affecting food intake in rats. Plant Foods Hum Nutr 63: 41-46.
12. Iqbal MS, Ghafoor A, Qureshi AS, Khan MR, Chaudhary UI (2009) Quantification and diversity in the black seeds (Nigella sativa L.): Gene stock of Pakistan for their composition of mineral nutrients. J Chem Soc Pak 31: 793-800.
13. Sultan MT, Butt MS, Anjum FM, Jamil A, Akhtar S, Nasir M (2009) Nutritional profile of indigenous cultivar of black cumin seeds and antioxidant potential of its fixed and essential oil. Pak J Bot 41: 1321-1330.
14. Amin S, Mir SR, Kohli K, Ali B, Ali M (2010) A study of the chemical composition of black cumin oil and its effect on penetration enhancement from transdermal formulations. Nat Prod Res 24: 1151-1157.
15. Butt MS, Sultan MT (2010) Nigella sativa: Reduces the risk of various maladies. Crit Rev Food Sci Nutr 50: 654-665.
16. Kokoska L (2011) Chemistry and biological activity of Nigella genus: the antimicrobial and anti-inflammatory effects of seed extracts, essential oils and compounds of six Nigella species. Lambert Academic Publishing, Saarbrücken.
17. Lutterodt H, Luther M, Slavin M, Yin JJ, Parry J, Gao JM, Yu LL (2010) Fatty acid profile, thymoquinone content, oxidative stability, and antioxidant properties of cold-pressed black cumin seed oils. LWT-Food Sci Technol 43: 1409-1413.
18. Ramadan MF, Morsel JT (2004) Oxidative stability of black cumin (Nigella sativa L.), coriander (Coriandrum sativum L.) and niger (Guizotia abyssinica Cass.) crude seed oils upon stripping. Eur J Lipid Sci Tech 106: 35-43.
19. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132: 2087-2102.
20. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA 104: 20466-20471.
21. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3: 565-574.
22. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
23. van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444: 875-880.
24. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52: 1766-1777.
25. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5: 493-506.
26. Kopelman PG (2000) Obesity as a medical problem. Nature 404: 635-643.
27. Rodriguez MC, Parra MD, Marques-Lopes I, De Morentin BE, Gonzalez A, Martinez JA (2005) Effects of two energy-restricted diets containing different fruit amounts on body weight loss and macronutrient oxidation. Plant Foods Hum Nutr 60: 219-224.
28. Datau EA, Wardhana SEE, Pandelaki K, Langi JA, Fias (2010) Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 42: 130-134.
29. Suddek GM (2010) Thymoquinone-induced relaxation of isolated rat pulmonary artery. J Ethnopharmacol 127: 210-214.
30. Ebru U, Burak U, Yusuf S, Reyhan B, Arif K, Faruk TH, Emin M, Aydin K, Atilla II, Semsettin S, Kemal E (2008) Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats. Basic Clin Pharmacol Toxicol 103: 574-580.
31. Pourghassem-Gargari B, Ebrahimzadeh-Attary V, Rafraf M, Gorbani A (2009) Effect of dietary supplementation with Nigella sativa L. on serum lipid profile, lipid peroxidation and antioxidant defense system in hyperlipidemic rabbits. J Med Plants Res 3: 815-821.
32. Nader MA, El-Agamy DS, Suddek GM (2010) Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch Pharm Res 33: 637-643.
33. Jaffe T, Schwartz B (2008) Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123: 2543-2556.
34. Salim EI (2010) Cancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassay. Oncology Lett 1: 913-924.
35. Kohle C, Badary OA, Nill K, Bock-Hennig BS, Bock KW (2005) Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 69: 1397-1402.
36. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R (2004) Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 25: 857-866.
37. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA (2004) Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anti-Cancer Drug 15: 389-399.
38. Roepke M, Diestel A, Bajbouj K, Schonfeld P, Roessner A, Gali-Muhtasib H, Schneider-Stock R (2007) Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Pathol Res Pract 203: 340.
39. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK (2003) In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22: 107-113.
40. Koka PS, Mondal D, Schultz M, Abdel-Mageed AB, Agrawal KC (2010) Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: Role of reactive oxygen species. Exp Biol Med 235: 751-760.
41. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM (2010) Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention. J Natl Cancer I 102: 14-25.
42. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med 113: 71-88.
43. Alenzi FQ, El-Bolkiny YES, Salem ML (2010) Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Brit J Biomed Sci 67: 20-28.
44. Jafri SH, Glass J, Shi RH, Zhang SL, Prince M, Kleiner-Hancock H (2010) Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. J Exp Clin Canc Res 29: 87.
45. Effenberger-Neidnicht K, Schobert R (2011) Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol 67: 867-874.
46. Rathmann W, Giani G (2004) Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 2568-2569, author reply 2569.
47. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17: 961-969.
48. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122: 481-486.
49. Benhaddou-Andaloussi A, Martineau LC, Vallerand D, Haddad Y, Afshar A, Settaf A, Haddad PS (2010) Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes Metab 12: 148-157.
50. Fararh KM, Shimizu Y, Shiina T, Nikami H, Ghanem MM, Takewaki T (2005) Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet Sci 79: 219-223.
51. Kanter M, Meral I, Yener Z, Ozbek H, Demir H (2003) Partial regeneration/proliferation of the beta-cells in the islets of langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med 201: 213-219.
52. Samartin S, Chandra RK (2001) Obesity, overnutrition and the immune system. Nutr Res 21: 243-262.
53. Haq A, Abdullatif M, Lobo PI, Khabar KSA, Sheth KV, Alsedairy ST (1995) Nigella-Sativa-effect on human-lymphocytes and polymorphonuclear leukocyte phagocytic-activity. Immunopharmacology 30: 147-155.
54. Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T (2004) Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res Vet Sci 77: 123-129.
55. Haq A, Lobo PI, Al-Tufail M, Rama NR, Al-Sedairy ST (1999) Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int J Immunopharmacol 21: 283-295.
56. El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H (2006) Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett 106: 72-81.
57. Shahzad M, Yang XD, Asim MBR, Sun QZ, Han Y, Zhang FJ, Cao YX, Lu SM (2009) Black seed oil ameliorates allergic airway inflammation by inhibiting T-cell proliferation in rats. Pulm Pharmacol Ther 22: 37-43.
58. Woo CC, Kumar AP, Sethi G, Tan KH (2012) Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochem Pharmacol 83: 443-451.
59. Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14: 323-328.
60. Badary OA, Taha RA, El-Din AMG, Abdel-Wahab MH (2003) Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 26: 87-98.
61. Khalife KH, Lupidi G (2008) Reduction of hypervalent states of myoglobin and hemoglobin to their ferrous forms by thymoquinone: The role of GSH, NADH and NADPH. Bba-Gen Subjects 1780: 627-637.
62. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B (2008) Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. Cr Biol 331: 48-55.
63. Abdel-Wahhab MA, Aly SE (2005) Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol 25: 218-223.
64. Kanter M, Meral I, Dede S, Cemek M, Ozbek H, Uygan I, Gunduz H (2003) Effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and some liver enzymes in CCl4-treated rats. J Vet Med A 50: 264-268.
65. Bourgou S, Pichette A, Marzouk B, Legault J (2010) Bioactivities of black cumin essential oil and its main terpenes from Tunisia. S Afr J Bot 76: 210-216.
66. Ismail M, Al-Naqeep G, Chan KW (2010) Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radical Bio Med 48: 664-672.
67. Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M (2002) Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9: 69-74.
68. Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Elmazar MMA (1998) Acute and subchronic toxicity of thymoquinone in mice. Drug Develop Res 44: 56-61.
69. Al-Amri A, Bamosa A (2009) Phase I safety and clinical activity study of thymoquinone in patients with advanced refractory malignant disease. SEMJ 10: 107-111.
70. Nergiz C, Otles S (1993) Chemical-composition of Nigella-sativa L. seeds. Food Chem 48: 259-261.